Back to AVTX
FARALLON CAPITAL MANAGEMENT, L.L.C. → AVTX
FARALLON CAPITAL MANAGEMENT, L.L.C. AVTX Position History
Avalo Therapeutics, Inc. • Healthcare
Quarters held
1
Latest value
$46.2M
Q2 2026
Peak value
$46.2M
First seen
Q2 2026
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $46.2M | 2.50M | — | — |